Abstract:AIM To assess the effect of ACE inhibitor and Ang II type 1 (AT1) receptor antagonist in preventing hepatic fibrosis caused by CCl4 administration in rats; to investigate whether or not there are expression of AT 1 receptors on hepatic stellate cells; and to observe the effect of Ang II on proliferation and ECM synthesis of cultured HSCs.METHODS Studies were conducted in male Sprague-Dawley rats. Except for the hepatofibrotic model group and the control group, in three treated groups, either enalapril (5 mg/kg), or losartan (10 mg/kg), or enalapril + losartan were given to the fibrotic rats by daily gavage, and saline vehicle was given to model and normal control rats, After 6 weeks, liver fibrosis was assessed directly by hepatic morphometric analysis, which has been considered the gold standard for the quantification of fibrosis, The expressions of AT 1 receptors and (alpha -mooth muscle actin, alpha -SMA) in liver tissue or isolated hepatic stellate cells (HSCs) were detected by immunohistochemical techniques, The effect of Ang IT. on HSC proliferation was determined by MTT method, Effect of Ang IT on collagen synthesis of HSCs was determined by H-3-proline incorporation.RESULTS Contrasted to the fibrosis in rats of the model group, groups of rats treated with either enalapril or losartan, or a combination of two drugs showed a limited expansion of the interstitium (4.23 +/- 3.70 vs 11.22 +/- 4.79, P<0.05), but no difference was observed among three treated groups (5.38 +/- 3.43, 4.96 +/- 2.96, 4.23 +/- 2.70, P>0.05). Expression of AT 1 receptors was found in fibrotic interstitium of fibrotic rats, whereas in normal control rats they were limited to vasculature only to a very slight degree, AT 1 receptors were also expressed on activated HSCs in the culture, At concentrations from 10(-9) to 10(-5) mol/L, Ang II stimulated HSC proliferation in culture in a dose-dependent manner, Increasing Ang II concentrations produced corresponding increases in H-3-proline incorporation, Differences among groups were significant,CONCLUSION Angiotensin-converting enzyme inhibitors and AT 1 blocker may slow the progression of hepatic fibrosis; activated HSCs express AT 1 receptors, and Ang II can stimulate the proliferation and collagen synthesis of HSCs in a dose-dependent manner; and activation of RAS may be related to hepatic fibrogenesis induced by CCl4.

Angiotensin II regulates liver regeneration via type 1 receptor following partial hepatectomy in mice

Angiotensin II depends on hippo/YAP signaling to reprogram angiogenesis and promote liver fibrosis

Angiotensin II type-2 receptor signaling facilitates liver injury repair and regeneration via inactivation of Hippo pathway

The Regulatory Role of AT1 Receptor on Activated HSCs in Hepatic Fibrogenesis: Effects of RAS Inhibitors on Hepatic Fibrosis Induced by CCl4

Relation of Angiotensin Ⅱ and Its Receptor AT1R with Liver Fibrosis

The role of angiotensinⅡperfusion in fatty liver injury

Abstract 374: Smooth Muscle Cell-specific Deletion Of At1a Receptor Attenuates Vascular Fibrosis In Angiotensin Ii-infused Mice

Effects of Angiotensin II Receptor Blockade on Hepatic Fibrosis in Rats.

Angiotensin-(1–1) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor

Effects of renin-angiotensin system inhibitors on hepatic fibrosis

Angiotensin-I-Converting Enzyme Inhibitors May Be an Alternative Anti-Angiogenic Strategy in the Treatment of Liver Fibrosis and Hepatocellular Carcinoma

Angiotensin II Type 1a Receptor is Involved in Cell Infiltration, Cytokine Production, and Neovascularization in Infarcted Myocardium

Angiotensin II type 1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction

Angiotensin II Enhances Proliferation and Inflammation through AT1/PKC/NF-κB Signaling Pathway in Hepatocellular Carcinoma Cells

Effects of Angiotensin II Type 2 Receptor Overexpression on the Growth of Hepatocellular Carcinoma Cells in Vitro and in Vivo.

Central Angiotensin II type 1 receptor deficiency alleviates renal fibrosis by reducing sympathetic nerve discharge in nephrotoxic folic acid-induced chronic kidney disease

Inhibition of TGF1 accelerates regeneration of fibrotic rat liver elicited by a novel two-staged hepatectomy

Hepatocyte Growth Factor Inhibits Renal Angiotensin II Expression in 5/6 Nephrectomized Rats

Angiotensin II: a key mediator in the development of liver fibrosis and cancer

Endothelial Cell-Derived Angiopoietin-2 Controls Liver Regeneration As a Spatiotemporal Rheostat

Inhibition of TGFβ1 accelerates regeneration of fibrotic rat liver elicited by a novel two-staged hepatectomy